Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitorsRONGHUI LIN; CHIU, George; YANG YU et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 16, pp 4557-4561, issn 0960-894X, 5 p.Article

Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRONGHUI LIN; JOHNSON, Sigmond G; FUENTES-PESQUERA, Angel R et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 8, pp 2333-2337, issn 0960-894X, 5 p.Article

Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agentsRONGHUI LIN; CONNOLLY, Peter J; GRUNINGER, Robert H et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 15, pp 4297-4302, issn 0960-894X, 6 p.Article

1-acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors : Synthesis and evaluation of biological activities : 2005 American Chemical Society Award for Computers in Chemical and Pharmaceutical ResearchRONGHUI LIN; CONNOLLY, Peter J; MIDDLETON, Steven A et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 13, pp 4208-4211, issn 0022-2623, 4 p.Article

7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors : Design, synthesis, and biological activityHUGHES, Terry V; EMANUEL, Stuart L; O'GRADY, Harold R et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 18, pp 5130-5133, issn 0960-894X, 4 p.Article

4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluationHUGHES, Terry V; EMANUEL, Stuart L; MIDDLETON, Steven A et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 12, pp 3266-3270, issn 0960-894X, 5 p.Article

3-acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors : Synthesis and biological evaluationRONGHUI LIN; YANHUA LU; PANDEY, Niranjan et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 9, pp 2221-2224, issn 0960-894X, 4 p.Article

A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivoLAMONTAGNE, Kenneth R; BUTLER, Jeannene; BOROWSKI, Virna B et al.Angiogenesis (London). 2009, Vol 12, Num 3, pp 287-296, issn 0969-6970, 10 p.Article

4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitorsGUOZHANG XU; ABAD, Marta C; MORENO-MAZZA, Sandra et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 16, pp 4615-4619, issn 0960-894X, 5 p.Article

Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinasesGUOZHANG XU; LILY LEE SEARLE; GRUNINGER, Robert H et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 12, pp 3495-3499, issn 0960-894X, 5 p.Article